Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 348 entries
View as:

A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

Phase: N/A Priority: Normal
NCT ID: NCT06024408 Org: User:
Start: 05/21/24 End: 07/08/25 Due: 07/08/26

Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03761108 Org: User:
Start: 01/23/19 End: 06/24/32 Due: 06/24/33

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03936335 Org: User:
Start: 09/30/19 End: 07/21/27 Due: 07/21/28

COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04992273 Org: User:
Start: 09/13/21 End: 06/01/22 Due: 06/01/23

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05568459 Org: User:
Start: 01/17/24 End: 04/02/26 Due: 04/02/27

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04203797 Org: User:
Start: 07/16/20 End: 07/15/23 Due: 07/15/24

A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018

Phase: N/A Priority: Normal
NCT ID: NCT04590326 Org: User:
Start: 12/09/20 End: 04/27/27 Due: 04/27/28

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)

Phase: N/A Priority: Normal
NCT ID: NCT06769412 Org: User:
Start: 07/01/25 End: 09/01/25 Due: 09/01/26

A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06413680 Org: User:
Start: 09/23/24 End: 02/03/30 Due: 02/03/31

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05730036 Org: User:
Start: 09/18/23 End: 04/19/33 Due: 04/19/34

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06769698 Org: User:
Start: 03/26/25 End: 11/28/29 Due: 11/28/30

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05955508 Org: User:
Start: 01/30/24 End: 12/19/32 Due: 12/19/33

Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04616105 Org: User:
Start: 11/18/20 End: 05/28/21 Due: 05/28/22

An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

Phase: N/A Priority: Normal
NCT ID: NCT05363319 Org: User:
Start: 10/26/22 End: 10/30/28 Due: 10/30/29

A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03956550 Org: User:
Start: 05/21/19 End: 10/29/20 Due: 10/29/21

Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04491838 Org: User:
Start: 08/03/20 End: 03/05/21 Due: 03/05/22

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03050151 Org: User:
Start: 02/28/17 End: 02/12/18 Due: 02/12/19

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Phase: N/A Priority: Normal
NCT ID: NCT06064656 Org: User:
Start: 06/29/23 End: 09/29/23 Due: 09/29/24

A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01026519 Org: User:
Start: 09/30/08 End: 05/31/09 Due: 05/31/10

Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)

Phase: N/A Priority: Normal
NCT ID: NCT01709500 Org: User:
Start: 12/31/12 End: 01/31/15 Due: 01/31/16

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

Phase: N/A Priority: Normal
NCT ID: NCT05590585 Org: User:
Start: 01/11/23 End: 11/14/24 Due: 11/14/25

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03345914 Org: User:
Start: 11/17/17 End: 09/10/19 Due: 09/10/20

Compassionate Use of Vidutolimod

Phase: N/A Priority: Normal
NCT ID: NCT06063746 Org: User:
Start: - End: - Due: -

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06465329 Org: User:
Start: 11/18/24 End: 05/21/30 Due: 05/21/31

REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04409080 Org: User:
Start: 01/13/21 End: 07/13/26 Due: 07/13/27